Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909062 · ClinicalTrials.gov registry record
Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 54
- Enrollment target
NCT02909062: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02909062 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909062 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
Electronic activity monitoring (EAM) devices are wearable electronic devices that monitor functional activity and provide personal feedback on activity progression. This study aims to determine if EAM can provide an objective, assessment of patient functional activity. The study will also examine the change in functional activity experienced by patients during the first cycle of chemotherapy. Another objective of the study will be to see if baseline functional activity and the change in functional activity that occurs during the first cycle of chemotherapy can be used to predict patient tolerability of subsequent cycles of chemotherapy.
Interventions
- DEVICE Electronic Activity Monitoring (EAM)
- BEHAVIORAL Daily Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02909062
The ClinicalTrials.gov registry entry for NCT02909062 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Activity Monitoring (EAM) is the first listed.
NCT02909062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02909062 about?
NCT02909062 is a clinical study titled "Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.". Electronic activity monitoring (EAM) devices are wearable electronic devices that monitor functional activity and provide personal feedback on activity progression. This study aims to determine if EAM can provide an objective, assessment of patient functional activity. The study will also examine th...
What is the current status of trial NCT02909062?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2016-05. Estimated completion is 2020-08-21.
What interventions are being tested in trial NCT02909062?
The interventions under investigation include: Electronic Activity Monitoring (EAM) (DEVICE), Daily Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02909062?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.